Innovative kidney reversal medicines
Funding Target
₹500,000,000
Last Month Rev
₹0
Valuation Ask
₹0
Business & Revenue Model
| Revenue Model | SaaS |
| Financing Instrument | Equity |
| Equity Offered | N/A% |
| 6-Mo Avg Revenue | ₹0 |
Corporate Information
| Registered Company | Clement MedLife Solutions |
| Corporate ID (CIN) | U46497UP2023PTC192997 |
| Year Established | N/A |
| Team Strength | 25 Members |
Nephrogen Pitch Deck Prospectus
Pitch deck hidden
Please login to view the pitch deck.
Nephrogen Video Pitch Presentation
Video Presentation Unavailable
No active YouTube pitch video was found for this prospectus.